American trade names of the drugs: Daunorubicin: Cerubidin; Vincristine: Oncovin, Vincasar PFS, Vincristine Sulfate injection; L-Asparaginase: Elspar; Cyclophosphamide: Cytoxan, Neosar; Cytosine arabinoside: Cytarabine, Cytosar-U; Etoposide: VePesid, Toposar, Etoposide for injection; Idarubicin: IDA; 6-Thioguanine: Thioguanine Tabloid; Methotrexate: Methotrexate LPF, Methotrexate Sodium for injection; Ifosfamide: Ifex; Cisplatin: Cisplatin injection, Platinol; Epirubicine: Ellenca.
Chemotherapy induced transverse leukonychia in children
Article first published online: 3 JUN 2003
International Journal of Dermatology
Volume 42, Issue 6, pages 468–469, June 2003
How to Cite
Yoruk, A. and Yukselgungor, H. (2003), Chemotherapy induced transverse leukonychia in children. International Journal of Dermatology, 42: 468–469. doi: 10.1046/j.1365-4362.2003.01727.x
- Issue published online: 3 JUN 2003
- Article first published online: 3 JUN 2003
Transverse white nail banding can be inherited or caused by various diseases and medications, including cancer chemotherapeutic agents, retinoids, tetracyclines, antimalarials, sulfonamides, pilocarpine, cortisone and zidovudine. Neither a specific drug nor classes of cancer chemotherapeutics were associated more frequently than the other with acquired transverse leukonychia in patients with cancer.
Here we report transverse leukonychia in four children with cancer receiving different chemotherapeutic agents.